Ost-müük Novartis Adr Repsg 1 - USD - NVS CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.30 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.030779% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | -0.013666% | ||||||||
Ööpäeva tasu aeg | 22:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Novartis AG ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Eelmine sulgemine* | 88.17 |
Avatud* | 86.28 |
Aastane muutus* | -2.11% |
Päeva ulatus* | 85.6 - 86.28 |
52 nädala ulatus | 74.09-94.26 |
Keskmine maht (10 päeva) | 2.22M |
Keskmine maht (3 kuud) | 40.93M |
Turukapitalisatsioon | 212.32B |
P/E suhtarv | 27.92 |
Ringluses olevad aktsiad | 2.12B |
Tulu | 51.74B |
EPS | 3.16 |
Dividendid (% kasumist) | 3.76884 |
Beeta | 0.52 |
Järgmine tuluaruande kuupäev | Apr 25, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Feb 2, 2023 | 86.07 | -0.40 | -0.46% | 86.47 | 86.53 | 85.42 |
Feb 1, 2023 | 88.17 | 0.10 | 0.11% | 88.07 | 88.52 | 85.97 |
Jan 31, 2023 | 90.53 | 1.00 | 1.12% | 89.53 | 90.59 | 89.10 |
Jan 30, 2023 | 89.55 | -0.48 | -0.53% | 90.03 | 90.36 | 89.36 |
Jan 27, 2023 | 89.43 | 0.13 | 0.15% | 89.30 | 89.95 | 89.20 |
Jan 26, 2023 | 89.63 | -1.31 | -1.44% | 90.94 | 91.03 | 89.29 |
Jan 25, 2023 | 92.72 | 0.62 | 0.67% | 92.10 | 92.83 | 92.09 |
Jan 24, 2023 | 91.80 | 0.54 | 0.59% | 91.26 | 92.10 | 90.32 |
Jan 23, 2023 | 91.95 | 0.20 | 0.22% | 91.75 | 92.47 | 91.71 |
Jan 20, 2023 | 92.02 | 0.06 | 0.07% | 91.96 | 92.02 | 91.18 |
Jan 19, 2023 | 92.19 | 0.17 | 0.18% | 92.02 | 92.32 | 91.83 |
Jan 18, 2023 | 92.05 | -1.15 | -1.23% | 93.20 | 93.21 | 91.97 |
Jan 17, 2023 | 92.32 | -0.85 | -0.91% | 93.17 | 93.17 | 92.18 |
Jan 13, 2023 | 91.02 | 0.38 | 0.42% | 90.64 | 91.23 | 90.37 |
Jan 12, 2023 | 90.48 | 0.49 | 0.54% | 89.99 | 90.83 | 89.59 |
Jan 11, 2023 | 90.23 | -0.62 | -0.68% | 90.85 | 90.93 | 90.01 |
Jan 10, 2023 | 90.20 | 0.02 | 0.02% | 90.18 | 90.79 | 89.73 |
Jan 9, 2023 | 89.66 | -3.26 | -3.51% | 92.92 | 93.20 | 89.32 |
Jan 6, 2023 | 92.20 | 1.13 | 1.24% | 91.07 | 92.39 | 90.50 |
Jan 5, 2023 | 90.75 | -0.25 | -0.27% | 91.00 | 91.20 | 90.41 |
Novartis Adr Repsg 1 - USD Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Kogutulu | 49386 | 43361 | 46017 | 48624 | 49898 | 52877 |
Tulu | 49386 | 43361 | 46017 | 48624 | 49898 | 52877 |
Kulud, Kokku | 17338 | 13416 | 13555 | 13930 | 14400 | 15435 |
Brutokasum | 32048 | 29945 | 32462 | 34694 | 35498 | 37442 |
Kogu tegevuskulu | 41111 | 34658 | 31824 | 39538 | 39746 | 41188 |
Müük/Üldine/admin kulud, kokku | 14111 | 12468 | 13690 | 14319 | 14093 | 14815 |
Uuringud ja arendus | 8402 | 7808 | 8154 | 8386 | 8484 | 9041 |
Depreciation / Amortization | 43 | 187 | 179 | 50 | 64 | 109 |
Ootamatud kulutused (tulu) | 911 | 395 | -4309 | 2284 | 2503 | 1173 |
Other Operating Expenses, Total | 306 | 384 | 549 | 607 | 538 | 653 |
Tulud majandustegevusest | 8275 | 8703 | 14193 | 9086 | 10152 | 11689 |
Intressitulud (kulu), muud tulud, neto | -440 | 418 | -5 | -36 | -146 | 14628 |
Muud, neto | -18 | -19 | -93 | -110 | -128 | -180 |
Netotulu enne makse | 7817 | 9102 | 14095 | 8940 | 9878 | 26137 |
Netotulu pärast makse | 6698 | 7499 | 12800 | 7147 | 8071 | 24018 |
Vähemuse intress | 14 | 0 | -3 | -5 | 1 | 3 |
Netotulu enne erikulusid | 6712 | 7499 | 12797 | 7142 | 8072 | 24021 |
Netotulu | 6712 | 7703 | 12611 | 11732 | 8072 | 24021 |
Arvestatav tulu, v a erikulud | 6712 | 7499 | 12797 | 7142 | 8072 | 24021 |
Arvestatav tulu, koos erikuludega | 6712 | 7703 | 12611 | 11732 | 8072 | 24021 |
Jaotuse korrigeerimine | 0 | |||||
Jaotamisele kuuluv netotulu | 6712 | 7703 | 12611 | 11732 | 8072 | 24021 |
Keskmine jaotamisele kuuluv aktsia kohta | 2400 | 2371 | 2344 | 2319 | 2296 | 2260 |
Jaotatav EPS, v a erakorralised kulud | 2.79667 | 3.1628 | 5.45947 | 3.07978 | 3.51568 | 10.6288 |
Dividends per Share - Common Stock Primary Issue | 2.71795 | 2.71776 | 2.93645 | 2.83413 | 3.08737 | 3.19907 |
Jaotamisele kuuluv normaal-EPS | 3.12191 | 3.30006 | 3.79006 | 3.86715 | 4.40641 | 11.1183 |
Erakorralised kulud kokku | 204 | -186 | 4590 | |||
Intressikulu (tulu) - neto majandustegevusest | 6 | -38 | -336 | -38 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Kogutulu | 12694 | 13294 | 13367 | 13522 | 12814 |
Tulu | 12694 | 13294 | 13367 | 13522 | 12814 |
Kulud, Kokku | 3833 | 3754 | 3848 | 4000 | 3755 |
Brutokasum | 8861 | 9540 | 9519 | 9522 | 9059 |
Kogu tegevuskulu | 10279 | 9815 | 10134 | 10960 | 9962 |
Müük/Üldine/admin kulud, kokku | 3520 | 3710 | 3601 | 3984 | 3498 |
Uuringud ja arendus | 2127 | 2284 | 2261 | 2369 | 2256 |
Depreciation / Amortization | 27 | 27 | 25 | 30 | 35 |
Intressikulu (tulu) - neto majandustegevusest | -101 | 60 | -9 | 12 | 102 |
Ootamatud kulutused (tulu) | 690 | -136 | 312 | 307 | 193 |
Other Operating Expenses, Total | 183 | 116 | 96 | 258 | 123 |
Tulud majandustegevusest | 2415 | 3479 | 3233 | 2562 | 2852 |
Intressitulud (kulu), muud tulud, neto | 54 | 38 | 21 | 14415 | -203 |
Muud, neto | -19 | -11 | -24 | -26 | 20 |
Netotulu enne makse | 2450 | 3506 | 3230 | 16951 | 2669 |
Netotulu pärast makse | 2059 | 2895 | 2758 | 16306 | 2219 |
Vähemuse intress | 0 | 1 | 0 | 2 | 3 |
Netotulu enne erikulusid | 2059 | 2896 | 2758 | 16308 | 2222 |
Netotulu | 2059 | 2896 | 2758 | 16308 | 2222 |
Arvestatav tulu, v a erikulud | 2059 | 2896 | 2758 | 16308 | 2222 |
Arvestatav tulu, koos erikuludega | 2059 | 2896 | 2758 | 16308 | 2222 |
Jaotamisele kuuluv netotulu | 2059 | 2896 | 2758 | 16308 | 2222 |
Keskmine jaotamisele kuuluv aktsia kohta | 2265 | 2243 | 2254 | 2257 | 2237 |
Jaotatav EPS, v a erakorralised kulud | 0.90905 | 1.29113 | 1.2236 | 7.22552 | 0.99329 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 3.19907 | 0 |
Jaotamisele kuuluv normaal-EPS | 1.16507 | 1.24106 | 1.3418 | 7.35637 | 1.06502 |
- Aastas
- Kvartalis
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Käibevarad kokku | 24931 | 28208 | 35563 | 29504 | 29673 | 45718 |
Raha ja lühiajalised investeeringud | 7546 | 9347 | 15718 | 11234 | 11293 | 28113 |
Cash | 1912 | 2970 | 3121 | 3247 | 3750 | 3396 |
Raha ja ekvivalendid | 5095 | 5890 | 10150 | 7865 | 5908 | 9011 |
Lühiajalised investeeringud | 539 | 487 | 2447 | 122 | 1635 | 15706 |
Laekumata arved, neto | 10208 | 11101 | 11036 | 10337 | 10036 | 9621 |
Accounts Receivable - Trade, Net | 8203 | 8601 | 8739 | 8301 | 8217 | 8005 |
Total Inventory | 6255 | 6867 | 6956 | 5982 | 7131 | 6666 |
Prepaid Expenses | 692 | 756 | 812 | 898 | 943 | 1102 |
Other Current Assets, Total | 230 | 137 | 1041 | 1053 | 270 | 216 |
Total Assets | 130124 | 133079 | 145563 | 118370 | 127778 | 131795 |
Property/Plant/Equipment, Total - Net | 15641 | 16464 | 15696 | 13746 | 13939 | 13106 |
Property/Plant/Equipment, Total - Gross | 31296 | 34010 | 34028 | 28676 | 29894 | 28708 |
Accumulated Depreciation, Total | -15655 | -17546 | -18332 | -14930 | -15955 | -15602 |
Goodwill, Net | 30980 | 31750 | 35294 | 26524 | 29999 | 29595 |
Intangibles, Net | 31340 | 29997 | 38719 | 28787 | 36809 | 34182 |
Long Term Investments | 15400 | 16645 | 9789 | 10538 | 11611 | 2268 |
Note Receivable - Long Term | 1100 | 968 | 908 | 624 | 922 | 973 |
Other Long Term Assets, Total | 10732 | 9047 | 9594 | 8647 | 4825 | 5953 |
Total Current Liabilities | 22209 | 23403 | 29607 | 28264 | 33059 | 30208 |
Accounts Payable | 4873 | 5169 | 5556 | 5424 | 5403 | 5553 |
Accrued Expenses | 4169 | 4811 | 5105 | 5058 | 5336 | 5100 |
Notes Payable/Short Term Debt | 5611 | 4842 | 6430 | 4844 | 7319 | 3606 |
Current Port. of LT Debt/Capital Leases | 178 | 359 | 3190 | 2248 | 2558 | 2896 |
Other Current Liabilities, Total | 7378 | 8222 | 9326 | 10690 | 12443 | 13053 |
Total Liabilities | 55292 | 58911 | 66949 | 62896 | 71180 | 64140 |
Total Long Term Debt | 17897 | 23224 | 22470 | 22056 | 27978 | 24523 |
Long Term Debt | 17897 | 23224 | 22470 | 20353 | 26259 | 22902 |
Deferred Income Tax | 6657 | 5168 | 7475 | 5867 | 3141 | 3070 |
Minority Interest | 59 | 59 | 78 | 77 | 68 | 167 |
Other Liabilities, Total | 8470 | 7057 | 7319 | 6632 | 6934 | 6172 |
Total Equity | 74832 | 74168 | 78614 | 55474 | 56598 | 67655 |
Common Stock | 972 | 969 | 944 | 936 | 913 | 901 |
Retained Earnings (Accumulated Deficit) | 81148 | 77639 | 82191 | 59274 | 57157 | 70989 |
Treasury Stock - Common | -76 | -100 | -69 | -80 | -53 | -48 |
Unrealized Gain (Loss) | 348 | 386 | 206 | |||
Other Equity, Total | -7560 | -4726 | -4658 | -4656 | -1419 | -4187 |
Total Liabilities & Shareholders’ Equity | 130124 | 133079 | 145563 | 118370 | 127778 | 131795 |
Total Common Shares Outstanding | 2374.06 | 2317.46 | 2311.17 | 2265.01 | 2256.82 | 2234.94 |
Capital Lease Obligations | 1703 | 1719 | 1621 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 22198 | 23808 | 26253 | 45718 | 37236 |
Raha ja lühiajalised investeeringud | 4077 | 5356 | 8162 | 28329 | 18814 |
Raha ja ekvivalendid | 3801 | 5117 | 7211 | 12407 | 13852 |
Lühiajalised investeeringud | 276 | 239 | 951 | 15922 | 4962 |
Laekumata arved, neto | 8481 | 8654 | 8632 | 8283 | 8678 |
Accounts Receivable - Trade, Net | 8265 | 8400 | 8377 | 8005 | 8409 |
Total Inventory | 6997 | 7111 | 6885 | 6666 | 6997 |
Other Current Assets, Total | 2643 | 2687 | 2574 | 2440 | 2747 |
Total Assets | 121752 | 124015 | 121209 | 131795 | 125218 |
Property/Plant/Equipment, Total - Net | 13204 | 13344 | 13157 | 13106 | 12861 |
Goodwill, Net | 29590 | 29766 | 29572 | 29595 | 29636 |
Intangibles, Net | 35377 | 34818 | 33951 | 34182 | 34853 |
Long Term Investments | 11628 | 12014 | 12347 | 3241 | 2906 |
Other Long Term Assets, Total | 9755 | 10265 | 5929 | 5953 | 7726 |
Total Current Liabilities | 30160 | 29633 | 29880 | 30208 | 29807 |
Accounts Payable | 5040 | 4811 | 4665 | 5553 | 5083 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 10400 | 9278 | 9528 | 6502 | 6902 |
Other Current Liabilities, Total | 14720 | 15544 | 15687 | 18153 | 17822 |
Total Liabilities | 71229 | 69973 | 64438 | 64140 | 63678 |
Total Long Term Debt | 27399 | 26491 | 24715 | 24523 | 24373 |
Long Term Debt | 25747 | 24828 | 23101 | 22902 | 22796 |
Capital Lease Obligations | 1652 | 1663 | 1614 | 1621 | 1577 |
Deferred Income Tax | 7393 | 7472 | 3349 | 3070 | 3384 |
Minority Interest | 66 | 86 | 166 | 167 | 164 |
Other Liabilities, Total | 6211 | 6291 | 6328 | 6172 | 5950 |
Total Equity | 50523 | 54042 | 56771 | 67655 | 61540 |
Common Stock | 913 | 913 | 901 | 901 | 901 |
Retained Earnings (Accumulated Deficit) | 49670 | 53194 | 55917 | 66802 | 60699 |
Treasury Stock - Common | -60 | -65 | -47 | -48 | -60 |
Total Liabilities & Shareholders’ Equity | 121752 | 124015 | 121209 | 131795 | 125218 |
Total Common Shares Outstanding | 2245.09 | 2236.74 | 2237.09 | 2234.94 | 2212.58 |
- Aastas
- Kvartalis
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netotulu/algväärtus | 6698 | 7499 | 12800 | 7147 | 8071 | 24018 |
Raha majandustegevusest | 11475 | 12621 | 14272 | 13625 | 13650 | 15071 |
Raha majandustegevusest | 1591 | 1460 | 1783 | 1852 | 2088 | 1807 |
Amortization | 4452 | 3276 | 3428 | 3974 | 4376 | 4306 |
Mittelikviidsed varad | 2239 | 1983 | -2315 | 3369 | 3842 | -11714 |
Cash Taxes Paid | 2111 | 1487 | 1506 | 1876 | 1833 | 2342 |
Makstud intressid | 723 | 697 | 816 | 793 | 703 | 664 |
Muutused tööjõus | -3505 | -1597 | -1424 | -2717 | -4727 | -3346 |
Tulu investeeringutelt | -3441 | -3119 | -5591 | -2226 | -13182 | 4208 |
Kapitalikulutused | -2879 | -2294 | -2648 | -2257 | -2585 | -2971 |
Muud rahavood investeeringutelt, kokku | -562 | -825 | -2943 | 31 | -10597 | 7179 |
Rahavood investeeringutelt | -5314 | -7733 | -4244 | -13627 | -2208 | -16264 |
Rahavoogudesse investeerimine | 1 | -101 | -119 | 3307 | -199 | 94 |
Total Cash Dividends Paid | -6475 | -6495 | -6966 | -6645 | -6987 | -7368 |
Aktsiate emiteerimine (tagasiost), neto | -895 | -5238 | -1336 | -5332 | -2094 | -3004 |
Laenu väljastamine (kustutamine), neto | 2055 | 4101 | 4177 | -4957 | 7072 | -5986 |
Muutused valuutakursside kõikumisest | -387 | 84 | -26 | 69 | 286 | -266 |
Rahaline kogumuutus | 2333 | 1853 | 4411 | -2159 | -1454 | 2749 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 2059 | 4954 | 7712 | 24018 | 2219 |
Cash From Operating Activities | 2130 | 6262 | 11187 | 15071 | 1649 |
Cash From Operating Activities | 514 | 893 | 1287 | 1807 | 392 |
Amortization | 1183 | 2248 | 3307 | 4306 | 1013 |
Non-Cash Items | 386 | 803 | 1732 | -11714 | 918 |
Cash Taxes Paid | 735 | 1144 | 1459 | 2342 | 633 |
Cash Interest Paid | 112 | 301 | 458 | 664 | 110 |
Changes in Working Capital | -2012 | -2636 | -2851 | -3346 | -2893 |
Cash From Investing Activities | 780 | 877 | -355 | 4208 | 9365 |
Capital Expenditures | -858 | -1455 | -1994 | -2971 | -859 |
Other Investing Cash Flow Items, Total | 1638 | 2332 | 1639 | 7179 | 10224 |
Cash From Financing Activities | -8540 | -11479 | -13013 | -16264 | -9528 |
Financing Cash Flow Items | -35 | 77 | 87 | 94 | 22 |
Total Cash Dividends Paid | -7368 | -7368 | -7368 | -7368 | -7506 |
Issuance (Retirement) of Stock, Net | -1892 | -2572 | -2856 | -3004 | -2448 |
Issuance (Retirement) of Debt, Net | 755 | -1616 | -2876 | -5986 | 404 |
Foreign Exchange Effects | -227 | -201 | -266 | -266 | -41 |
Net Change in Cash | -5857 | -4541 | -2447 | 2749 | 1445 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
JPMorgan Private Bank (United States) | Bank and Trust | 10.6401 | 225529101 | 225420578 | 2022-12-31 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 0.993 | 21048657 | -1504112 | 2022-09-30 | LOW |
PRIMECAP Management Company | Investment Advisor | 0.8234 | 17453150 | -150930 | 2022-09-30 | LOW |
Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 0.7044 | 14929752 | -555468 | 2022-09-30 | LOW |
Franklin Mutual Advisers, LLC | Investment Advisor/Hedge Fund | 0.3354 | 7110172 | -288168 | 2022-09-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.3068 | 6503191 | 465677 | 2022-09-30 | LOW |
Managed Account Advisors LLC | Investment Advisor | 0.2611 | 5534681 | 606410 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.24 | 5087602 | 482080 | 2022-09-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.2136 | 4527461 | 83210 | 2022-09-30 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.1674 | 3547598 | -646574 | 2022-09-30 | HIGH |
Schafer Cullen Capital Management, Inc. | Investment Advisor/Hedge Fund | 0.1636 | 3467273 | 103941 | 2022-09-30 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.1583 | 3355379 | 61238 | 2022-09-30 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 0.1575 | 3339270 | 149986 | 2022-09-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.1501 | 3181870 | -601500 | 2022-09-30 | HIGH |
Parametric Portfolio Associates LLC | Investment Advisor | 0.1273 | 2697639 | -319733 | 2022-09-30 | LOW |
Northern Trust Global Investments | Investment Advisor | 0.1168 | 2475187 | -138624 | 2022-09-30 | LOW |
Principal Global Investors (Equity) | Investment Advisor | 0.116 | 2458231 | 189855 | 2022-09-30 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.1105 | 2341152 | -263161 | 2022-09-30 | LOW |
Wells Fargo Advisors | Research Firm | 0.0936 | 1984665 | -300512 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.0909 | 1927277 | -42628 | 2022-09-30 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com GroupKauplejad
Igakuiste aktiivsete klientide arv
Igakuine investeerimise maht
Igakuiselt välja võetud
Kauplemiskalkulaator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Novartis ADR Company profile
Ettevõttest Novartis Adr Repsg 1 - USD
Novartis AG on Šveitsis asuv farmaatsiaettevõte. Ettevõte arendab, toodab ja turustab kaubamärgiga ja geneerilisi retseptiravimeid, toimeaineid, biosimilaare ja silmaarstitooteid. Ettevõte kasutab teadust ja digitaaltehnoloogiaid raviks immunoloogia, dermatoloogia, vähi, oftalmoloogia, neuroloogia, hingamisteede, südame- ja veresoonkonna, neerude ja ainevahetuse valdkonnas. Ettevõtte äritegevus jaguneb kahte segmenti: Innovative Medicines, mis hõlmab uuenduslikke patendikaitsega retseptiravimeid vererõhu, vähi ja muude haiguste raviks, ning Sandoz, mis hõlmab geneerilisi ravimeid ja biosimilaarseid ravimeid.
Industry: | Pharmaceuticals (NEC) |
Lichtstrasse 35
BASEL
BASEL-STADT 4056
CH
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 485,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com